应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
VVOS Vivos Therapeutics
休市中 08-21 16:00:00 EDT
0.2970
+0.0179
+6.41%
盘后
0.2994
+0.0024
+0.81%
19:17 EDT
最高
0.2996
最低
0.2802
成交量
12.28万
今开
0.2880
昨收
0.2791
日振幅
6.95%
总市值
597.50万
流通市值
524.41万
总股本
2,012万
成交额
3.54万
换手率
0.70%
流通股本
1,766万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Vivos Therapeutics 第二季度净亏损552.3万美元
投资观察 · 08-15
Vivos Therapeutics 第二季度净亏损552.3万美元
Vivos Therapeutics 深化与Greenway Health合作,将AI赋能平台全面部署至临床与收入运营
美股速递 · 08-11
Vivos Therapeutics 深化与Greenway Health合作,将AI赋能平台全面部署至临床与收入运营
Vivos Therapeutics宣布获得新美国专利,进一步扩大其Vivos Care口腔医疗设备技术保护范围
美股速递 · 08-05
Vivos Therapeutics宣布获得新美国专利,进一步扩大其Vivos Care口腔医疗设备技术保护范围
Vivos Therapeutics任命Roman Franklin为首席财务官,自2026年7月31日起生效——SEC文件披露
美股速递 · 08-04
Vivos Therapeutics任命Roman Franklin为首席财务官,自2026年7月31日起生效——SEC文件披露
Vivos Therapeutics与Streeterville协议延期至2026年8月31日,重申450万美元债务转换承诺
美股速递 · 06-22
Vivos Therapeutics与Streeterville协议延期至2026年8月31日,重申450万美元债务转换承诺
Vivos与Streeterville延长战略融资协议期限,并重申债务转普通股及永续优先股承诺
美股速递 · 06-22
Vivos与Streeterville延长战略融资协议期限,并重申债务转普通股及永续优先股承诺
Vivos Therapeutics与佛罗里达州多地点心脏专科集团达成关键合作协议,为心血管患者提供亟需的睡眠呼吸暂停与失眠诊疗服务
美股速递 · 06-10
Vivos Therapeutics与佛罗里达州多地点心脏专科集团达成关键合作协议,为心血管患者提供亟需的睡眠呼吸暂停与失眠诊疗服务
Vivos Therapeutics与Streeterville资本达成具约束力协议,进行最高450万美元优先债务转股权交易以维持纳斯达克上市地位
美股速递 · 06-05
Vivos Therapeutics与Streeterville资本达成具约束力协议,进行最高450万美元优先债务转股权交易以维持纳斯达克上市地位
Vivos Therapeutics完成与现有私募股权投资者New Seneca Partners的定向增发
美股速递 · 04-07
Vivos Therapeutics完成与现有私募股权投资者New Seneca Partners的定向增发
Vivos Therapeutics宣布成本削减计划:人员精简与供应商调整双管齐下
美股速递 · 03-26
Vivos Therapeutics宣布成本削减计划:人员精简与供应商调整双管齐下
Vivos Therapeutics, Inc.盘中异动 快速跳水5.96%
市场透视 · 2025-03-10
Vivos Therapeutics, Inc.盘中异动 快速跳水5.96%
Vivos Therapeutics, Inc.盘中异动 大幅拉升5.78%报3.66美元
市场透视 · 2025-03-07
Vivos Therapeutics, Inc.盘中异动 大幅拉升5.78%报3.66美元
Vivos Therapeutics, Inc.盘中异动 快速拉升5.25%
市场透视 · 2025-03-06
Vivos Therapeutics, Inc.盘中异动 快速拉升5.25%
Vivos Therapeutics, Inc.盘中异动 股价大跌5.68%
市场透视 · 2025-03-04
Vivos Therapeutics, Inc.盘中异动 股价大跌5.68%
Vivos Therapeutics, Inc.盘中异动 早盘急速下跌5.20%报3.28美元
市场透视 · 2025-02-25
Vivos Therapeutics, Inc.盘中异动 早盘急速下跌5.20%报3.28美元
Vivos Therapeutics, Inc.盘中异动 早盘急速上涨5.77%报3.30美元
市场透视 · 2025-02-24
Vivos Therapeutics, Inc.盘中异动 早盘急速上涨5.77%报3.30美元
Vivos Therapeutics, Inc.盘中异动 股价大跌5.59%
市场透视 · 2025-02-22
Vivos Therapeutics, Inc.盘中异动 股价大跌5.59%
Vivos Therapeutics, Inc.盘中异动 下午盘股价大跌5.08%
市场透视 · 2025-02-20
Vivos Therapeutics, Inc.盘中异动 下午盘股价大跌5.08%
Vivos Therapeutics, Inc.盘中异动 早盘股价大涨5.00%
市场透视 · 2025-02-18
Vivos Therapeutics, Inc.盘中异动 早盘股价大涨5.00%
Vivos Therapeutics, Inc.盘中异动 早盘急速下挫7.83%报3.92美元
市场透视 · 2025-02-14
Vivos Therapeutics, Inc.盘中异动 早盘急速下挫7.83%报3.92美元
加载更多
公司概况
公司名称:
Vivos Therapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
Vivos Therapeutics, Inc.最初于2016年7月7日在怀俄明州组建,并于2020年8月12日重新注册为特拉华州公司。该公司是一家处于创收阶段的医疗技术和医疗保健服务公司,提供用于治疗成人阻塞性睡眠呼吸暂停和打鼾的专有口腔矫治器和疗法。其综合方法称为Vivos疗法,包括经美国食品药品监督管理局批准的口腔矫治器和辅助治疗。
发行价格:
--
{"stockData":{"symbol":"VVOS","market":"US","secType":"STK","nameCN":"Vivos Therapeutics","latestPrice":0.297,"timestamp":1787342400000,"preClose":0.2791,"halted":0,"volume":122785,"hourTrading":{"tag":"盘后","latestPrice":0.2994,"preClose":0.297,"latestTime":"19:17 EDT","volume":12752,"amount":3627.5473,"timestamp":1787354279032,"change":0.0024,"changeRate":0.008081,"amplitude":0.064983},"delay":0,"changeRate":0.06413471873880319,"floatShares":17656800,"shares":20118000,"eps":-1.826661,"marketStatus":"休市中","change":0.0179,"latestTime":"08-21 16:00:00 EDT","open":0.288,"high":0.2996,"low":0.2802,"amount":35446.018281699995,"amplitude":0.069509,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.826661,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1607662800000,"exchange":"NASDAQ","adjPreClose":0.2791,"preHourTrading":{"tag":"盘前","latestPrice":0.2912,"preClose":0.2791,"latestTime":"08:53 EDT","volume":1338,"amount":376.85081754,"timestamp":1787316838312,"change":0.0121,"changeRate":0.043354,"amplitude":0.074884},"postHourTrading":{"tag":"盘后","latestPrice":0.2994,"preClose":0.297,"latestTime":"19:17 EDT","volume":12752,"amount":3627.5473,"timestamp":1787354279032,"change":0.0024,"changeRate":0.008081,"amplitude":0.064983},"volumeRatio":0.17741394803510674,"impliedVol":2.594,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/VVOS","defaultTab":"news","newsList":[{"id":"1114631302","title":"Vivos Therapeutics 第二季度净亏损552.3万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1114631302","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114631302?lang=zh_cn&edition=full","pubTime":"2026-08-15 04:39","pubTimestamp":1786739969,"startTime":"0","endTime":"0","summary":"在8月14日发布的财报中,Vivos Therapeutics 第二季度运营亏损达482.5万美元。这一数字,折射出公司当前面临的财务挑战。净亏损则进一步扩大,高达552.3万美元。业界观察者正密切关注其后续的扭亏策略。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VVOS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187703552","title":"Vivos Therapeutics 深化与Greenway Health合作,将AI赋能平台全面部署至临床与收入运营","url":"https://stock-news.laohu8.com/highlight/detail?id=1187703552","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187703552?lang=zh_cn&edition=full","pubTime":"2026-08-11 20:50","pubTimestamp":1786452612,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics 日前宣布,将扩大与 Greenway Health 的合作伙伴关系,旨在将AI驱动平台全面部署至其所有临床及收入运营环节。此次合作升级,标志着该公司在利用人工智能技术优化医疗流程、提升运营效率方面迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115370009","title":"Vivos Therapeutics宣布获得新美国专利,进一步扩大其Vivos Care口腔医疗设备技术保护范围","url":"https://stock-news.laohu8.com/highlight/detail?id=1115370009","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115370009?lang=zh_cn&edition=full","pubTime":"2026-08-05 20:33","pubTimestamp":1785933224,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics近日正式对外宣布,一项全新的美国专利已获授予。这项专利的获批,将显著拓宽其核心产品——Vivos Care口腔医疗设备技术的保护疆域。通过这项新专利,Vivos Therapeutics得以进一步捍卫其独特的技术路线,确保在市场竞争中占据更为有利的地位。值得注意的是,Vivos Care设备作为公司旗舰产品,主要针对睡眠呼吸障碍等复杂口腔健康问题。从战略层面分析,知识产权体系的持续强化,是Vivos Therapeutics在全球化布局中的关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VVOS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156246262","title":"Vivos Therapeutics任命Roman Franklin为首席财务官,自2026年7月31日起生效——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1156246262","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156246262?lang=zh_cn&edition=full","pubTime":"2026-08-04 05:32","pubTimestamp":1785792731,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics(股票代码:VVOS)已正式任命Roman Franklin担任公司首席财务官一职。这一任命将从2026年7月31日正式生效,相关详情已通过美国证券交易委员会(SEC)的文件予以披露。此次人事调整标志着公司财务管理层迎来新的掌舵者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VVOS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119984555","title":"Vivos Therapeutics与Streeterville协议延期至2026年8月31日,重申450万美元债务转换承诺","url":"https://stock-news.laohu8.com/highlight/detail?id=1119984555","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119984555?lang=zh_cn&edition=full","pubTime":"2026-06-22 20:31","pubTimestamp":1782131478,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics与Streeterville Capital已达成一致,将双方现有协议的有效期延长至2026年8月31日。此次延期,核心在于Streeterville Capital重申了其总额450万美元的债务转换承诺。协议条款的延续,为Vivos Therapeutics提供了更明确的资本结构前景。市场观察人士指出,此类承诺的延期与重申,通常反映了投资方对标的公司长期发展潜力的持续认可。对于Vivos Therapeutics而言,稳定的资本合作伙伴关系,在当前市场环境下显得尤为重要。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152788474","title":"Vivos与Streeterville延长战略融资协议期限,并重申债务转普通股及永续优先股承诺","url":"https://stock-news.laohu8.com/highlight/detail?id=1152788474","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152788474?lang=zh_cn&edition=full","pubTime":"2026-06-22 20:31","pubTimestamp":1782131475,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics与Streeterville已同意延长双方战略融资协议的执行时间框架。与此同时,两家公司再次确认了将既有债务转换为Vivos普通股及永续优先股的核心承诺。此举旨在为双方的战略合作提供更充裕的规划与执行空间,确保融资安排能够顺利推进,并进一步稳固公司的资本结构。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VVOS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161910314","title":"Vivos Therapeutics与佛罗里达州多地点心脏专科集团达成关键合作协议,为心血管患者提供亟需的睡眠呼吸暂停与失眠诊疗服务","url":"https://stock-news.laohu8.com/highlight/detail?id=1161910314","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161910314?lang=zh_cn&edition=full","pubTime":"2026-06-10 21:05","pubTimestamp":1781096733,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics宣布,已与一家在佛罗里达州设有多处诊疗地点的知名心脏专科集团达成一项关键合作协议。此项合作旨在将当前极为短缺的睡眠呼吸暂停及失眠诊断与治疗服务,扩展至广大的心血管疾病患者群体。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191227663","title":"Vivos Therapeutics与Streeterville资本达成具约束力协议,进行最高450万美元优先债务转股权交易以维持纳斯达克上市地位","url":"https://stock-news.laohu8.com/highlight/detail?id=1191227663","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191227663?lang=zh_cn&edition=full","pubTime":"2026-06-05 20:46","pubTimestamp":1780663574,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics宣布已与Streeterville资本签订一项具有法律约束力的协议,将进行一项最高金额达450万美元的优先债务转股权交易。此项融资安排旨在为公司提供必要资金支持,以确保其能够继续满足纳斯达克证券交易所的上市维持要求。通过这一结构性融资方案,Vivos Therapeutics不仅能够优化其资产负债表结构,降低债务负担,同时还能增强股东权益基础。Streeterville资本作为专业投资机构,此次参与体现了其对Vivos Therapeutics长期发展前景的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VVOS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169656711","title":"Vivos Therapeutics完成与现有私募股权投资者New Seneca Partners的定向增发","url":"https://stock-news.laohu8.com/highlight/detail?id=1169656711","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169656711?lang=zh_cn&edition=full","pubTime":"2026-04-07 20:46","pubTimestamp":1775565999,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics(股票代码:VVOS)近日宣布,已成功完成与现有私募股权投资者New Seneca Partners的定向增发交易。此次融资将进一步加强公司的资本结构,并为未来业务拓展提供资金支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VVOS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101074738","title":"Vivos Therapeutics宣布成本削减计划:人员精简与供应商调整双管齐下","url":"https://stock-news.laohu8.com/highlight/detail?id=1101074738","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101074738?lang=zh_cn&edition=full","pubTime":"2026-03-26 20:46","pubTimestamp":1774529176,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics Inc(简称:Vivos Therapeutics)最新披露了一项全面的成本优化战略。该计划核心包含两大关键举措:一是实施内部团队结构精简,二是启动供应商体系的战略性调整。\n通过这一系列精准的运营效率提升措施,公司旨在优化资源配置,强化财务韧性,为未来的可持续发展奠定更坚实的基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VVOS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518800279","title":"Vivos Therapeutics, Inc.盘中异动 快速跳水5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518800279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518800279?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:34","pubTimestamp":1741613667,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时34分,Vivos Therapeutics, Inc.股票出现异动,股价急速下挫5.96%。Vivos Therapeutics, Inc.股票所在的医疗器械行业中,整体跌幅为0.71%。其相关个股中,Biosig Technologies, Inc.、Trinity Biotech Plc、Pulmonx Corporation涨幅较大,Reshape Lifesciences, Inc.、古特拉、Tivic Health Systems, Inc.较为活跃,换手率分别为8.85%、8.14%、0.66%,振幅较大的相关个股有Orthofix Medical Inc.、Biosig Technologies, Inc.、古特拉,振幅分别为99.65%、6.68%、6.40%。Vivos Therapeutics, Inc.公司简介:Vivos Therapeutics Inc 是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213427a26a25cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213427a26a25cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4196","VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517516038","title":"Vivos Therapeutics, Inc.盘中异动 大幅拉升5.78%报3.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517516038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517516038?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:11","pubTimestamp":1741277466,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时11分,Vivos Therapeutics, Inc.股票出现波动,股价大幅上涨5.78%。截至发稿,该股报3.66美元/股,成交量4.3673万股,换手率0.74%,振幅8.38%。Vivos Therapeutics, Inc.股票所在的医疗器械行业中,整体跌幅为0.75%。其相关个股中,Pavmed Inc C/Wts 30/04/2025 Class Z、Envoy Medical, Inc.、Xylo Technologies Ltd涨幅较大,古特拉、Reshape Lifesciences, Inc.、908 Devices Inc.较为活跃,换手率分别为198.69%、12.16%、5.07%,振幅较大的相关个股有古特拉、Pavmed Inc C/Wts 30/04/2025 Class Z、飞天兆业,振幅分别为33.07%、26.00%、21.21%。Vivos Therapeutics, Inc.公司简介:Vivos Therapeutics Inc 是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307001106963c5fed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307001106963c5fed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","VVOS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517423509","title":"Vivos Therapeutics, Inc.盘中异动 快速拉升5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517423509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517423509?lang=zh_cn&edition=full","pubTime":"2025-03-06 01:01","pubTimestamp":1741194094,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日01时01分,Vivos Therapeutics, Inc.股票出现波动,股价急速拉升5.25%。Vivos Therapeutics, Inc.股票所在的医疗器械行业中,整体涨幅为0.62%。其相关个股中,Xylo Technologies Ltd、Cytosorbents Corporation、Xtant Medical Holdings, Inc.涨幅较大,古特拉、908 Devices Inc.、Tivic Health Systems, Inc.较为活跃,换手率分别为38.61%、23.47%、9.87%,振幅较大的相关个股有Pavmed Inc C/Wts 30/04/2025 Class Z、Ainos, Inc.、Heartsciences Inc.,振幅分别为40.00%、34.75%、23.28%。Vivos Therapeutics, Inc.公司简介:Vivos Therapeutics Inc 是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306010134989d67c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306010134989d67c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","VVOS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516650953","title":"Vivos Therapeutics, Inc.盘中异动 股价大跌5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516650953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516650953?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:40","pubTimestamp":1741030840,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时40分,Vivos Therapeutics, Inc.股票出现波动,股价急速跳水5.68%。Vivos Therapeutics, Inc.股票所在的医疗器械行业中,整体涨幅为1.38%。其相关个股中,Adagio Medical Holdings, Inc、Lensar, Inc.、Senseonics Holdings, Inc.涨幅较大,Reshape Lifesciences, Inc.、Sintx Technologies, Inc.、Bluejay Diagnostics, Inc.较为活跃,换手率分别为48.85%、17.67%、12.18%,振幅较大的相关个股有Nexalin Technology Inc C/Wts 、Ainos Inc C/Wts 29/07/2027 、Inspira Tech Oxy Bhn Ltd C/Wts 16/07/2026 ,振幅分别为71.96%、59.09%、40.86%。Vivos Therapeutics, Inc.公司简介:Vivos Therapeutics Inc 是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304034040989a53f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304034040989a53f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","LENZ","BK4139","VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514015668","title":"Vivos Therapeutics, Inc.盘中异动 早盘急速下跌5.20%报3.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514015668","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514015668?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:15","pubTimestamp":1740496555,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时15分,Vivos Therapeutics, Inc.股票出现波动,股价大幅跳水5.20%。Vivos Therapeutics, Inc.股票所在的医疗器械行业中,整体跌幅为0.38%。其相关个股中,Inspira Tech Oxy Bhn Ltd C/Wts 16/07/2026 、Adapthealth Corp.、Biosig Technologies, Inc.涨幅较大,Reshape Lifesciences, Inc.、Sintx Technologies, Inc.、Nano-X Imaging Ltd较为活跃,换手率分别为40.48%、5.79%、3.49%,振幅较大的相关个股有Inspira Tech Oxy Bhn Ltd C/Wts 16/07/2026 、Pavmed Inc C/Wts 30/04/2025 Class Z、Biosig Technologies, Inc.,振幅分别为125.32%、35.71%、31.19%。Vivos Therapeutics, Inc.公司简介:Vivos Therapeutics Inc 是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231555989256c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231555989256c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","VVOS","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513772790","title":"Vivos Therapeutics, Inc.盘中异动 早盘急速上涨5.77%报3.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513772790","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513772790?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:47","pubTimestamp":1740408453,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时47分,Vivos Therapeutics, Inc.股票出现异动,股价急速拉升5.77%。Vivos Therapeutics, Inc.股票所在的医疗器械行业中,整体跌幅为0.10%。其相关个股中,Pavmed Inc C/Wts 30/04/2025 Class Z、Nexalin Technology Inc C/Wts 、飞天兆业涨幅较大,Vivos Therapeutics, Inc.、Reshape Lifesciences, Inc.、Sintx Technologies, Inc.较为活跃,换手率分别为9.31%、8.30%、7.38%,振幅较大的相关个股有Pavmed Inc C/Wts 30/04/2025 Class Z、Nexalin Technology Inc C/Wts 、飞天兆业,振幅分别为100.00%、42.21%、30.67%。Vivos Therapeutics, Inc.公司简介:Vivos Therapeutics Inc 是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242247349890f9d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242247349890f9d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VVOS","LENZ","BK4139","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513136342","title":"Vivos Therapeutics, Inc.盘中异动 股价大跌5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513136342","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513136342?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:34","pubTimestamp":1740159292,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日01时34分,Vivos Therapeutics, Inc.股票出现异动,股价快速下挫5.59%。Vivos Therapeutics, Inc.股票所在的医疗器械行业中,整体跌幅为0.32%。其相关个股中,Ainos Inc C/Wts 29/07/2027 、Sintx Technologies, Inc.、Intelligent Bio Solutions Inc.涨幅较大,Sintx Technologies, Inc.、Reshape Lifesciences, Inc.、沃氪医疗较为活跃,换手率分别为190.29%、43.30%、20.92%,振幅较大的相关个股有Ainos Inc C/Wts 29/07/2027 、Pavmed Inc C/Wts 30/04/2025 Class Z、Nexalin Technology Inc C/Wts ,振幅分别为89.61%、59.52%、30.77%。Vivos Therapeutics, Inc.公司简介:Vivos Therapeutics Inc 是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222013452a24ed7fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222013452a24ed7fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4196","VVOS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512433912","title":"Vivos Therapeutics, Inc.盘中异动 下午盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512433912","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512433912?lang=zh_cn&edition=full","pubTime":"2025-02-20 02:44","pubTimestamp":1739990672,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日02时44分,Vivos Therapeutics, Inc.股票出现异动,股价快速下跌5.08%。Vivos Therapeutics, Inc.股票所在的医疗器械行业中,整体涨幅为0.58%。其相关个股中,Sintx Technologies, Inc.、Reshape Lifesciences, Inc.、飞天兆业涨幅较大,Sintx Technologies, Inc.、Reshape Lifesciences, Inc.、Bone Biologics Corp较为活跃,换手率分别为5004.25%、1074.76%、41.71%,振幅较大的相关个股有Sintx Technologies, Inc.、Reshape Lifesciences, Inc.、Ainos Inc C/Wts 29/07/2027 ,振幅分别为65.96%、50.00%、40.58%。Vivos Therapeutics, Inc.公司简介:Vivos Therapeutics Inc 是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220024433988b5989&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220024433988b5989&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4196","LENZ","VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512164411","title":"Vivos Therapeutics, Inc.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512164411","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512164411?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:53","pubTimestamp":1739894018,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时53分,Vivos Therapeutics, Inc.股票出现波动,股价大幅拉升5.00%。Vivos Therapeutics, Inc.股票所在的医疗器械行业中,整体跌幅为0.48%。其相关个股中,Anteris Technologies Global Corp.、Icecure Medical Ltd.、Biomerica, Inc.涨幅较大,Reshape Lifesciences, Inc.、Tivic Health Systems, Inc.、Allurion Technologies, Inc.较为活跃,换手率分别为583.46%、24.18%、18.54%,振幅较大的相关个股有Ainos Inc C/Wts 29/07/2027 、Bone Biologics Corp C/Wts 13/10/2026 、Dih Holdings Us Inc C/Wts 20/04/2028 ,振幅分别为28.77%、27.19%、20.25%。Vivos Therapeutics, Inc.公司简介:Vivos Therapeutics Inc 是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218235339988a0c67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218235339988a0c67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","BK4139","LENZ","VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511993766","title":"Vivos Therapeutics, Inc.盘中异动 早盘急速下挫7.83%报3.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511993766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511993766?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:32","pubTimestamp":1739543547,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时32分,Vivos Therapeutics, Inc.股票出现异动,股价大幅下跌7.83%。截至发稿,该股报3.92美元/股,成交量2.872万股,换手率0.49%,振幅1.95%。Vivos Therapeutics, Inc.股票所在的医疗器械行业中,整体涨幅为0.29%。其相关个股中,Envoy Medical Inc C/Wts 29/09/2028 、Avita Medical, Inc.、Envoy Medical, Inc.涨幅较大,Tivic Health Systems, Inc.、Nano-X Imaging Ltd、Neuropace, Inc.较为活跃,换手率分别为25.78%、3.02%、0.77%,振幅较大的相关个股有Envoy Medical Inc C/Wts 29/09/2028 、Pacific Biosciences Of California, Inc.、拜尔德医疗,振幅分别为13.14%、11.49%、10.88%。Vivos Therapeutics, Inc.公司简介:Vivos Therapeutics Inc 是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223227a2460105&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223227a2460105&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4196","VVOS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vivos.com","stockEarnings":[{"period":"1week","weight":-0.1349},{"period":"1month","weight":-0.2649},{"period":"3month","weight":-0.5131},{"period":"6month","weight":-0.8178},{"period":"1year","weight":-0.9354},{"period":"ytd","weight":-0.8537}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vivos Therapeutics, Inc.最初于2016年7月7日在怀俄明州组建,并于2020年8月12日重新注册为特拉华州公司。该公司是一家处于创收阶段的医疗技术和医疗保健服务公司,提供用于治疗成人阻塞性睡眠呼吸暂停和打鼾的专有口腔矫治器和疗法。其综合方法称为Vivos疗法,包括经美国食品药品监督管理局批准的口腔矫治器和辅助治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.205284},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.068873},{"month":3,"riseRate":0,"avgChangeRate":-0.209794},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.183475},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.065034},{"month":6,"riseRate":0.5,"avgChangeRate":-0.015118},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.103228},{"month":8,"riseRate":0.5,"avgChangeRate":0.096235},{"month":9,"riseRate":0,"avgChangeRate":-0.252021},{"month":10,"riseRate":0.2,"avgChangeRate":-0.105489},{"month":11,"riseRate":0.4,"avgChangeRate":1.251693},{"month":12,"riseRate":0.2,"avgChangeRate":-0.12992}],"exchange":"NASDAQ","name":"Vivos Therapeutics","nameEN":"Vivos Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vivos Therapeutics(VVOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Vivos Therapeutics(VVOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Vivos Therapeutics,VVOS,Vivos Therapeutics股票,Vivos Therapeutics股票老虎,Vivos Therapeutics股票老虎国际,Vivos Therapeutics行情,Vivos Therapeutics股票行情,Vivos Therapeutics股价,Vivos Therapeutics股市,Vivos Therapeutics股票价格,Vivos Therapeutics股票交易,Vivos Therapeutics股票购买,Vivos Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vivos Therapeutics(VVOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Vivos Therapeutics(VVOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}